文献速递神经免疫

Kappa游离轻链指数鉴别MOGAD、NMOSD与MS的诊断价值

Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.
PubMed 文献 · Neurology · 2026-04-01

本研究为法国18中心回顾性病例对照研究,纳入140例MOGAD、37例AQP4-NMOSD和126例MS患者,评估脑脊液Kappa游离轻链指数(KFLC-Index)鉴别三种疾病的诊断性能,并与脑脊液寡克隆区带(OCB)比较。结果显示KFLC-Index在鉴别MOGAD与MS时AUC达0.93,最佳阈值5.7,敏感度和特异度均为0.89;KFLC-Index未显著优于OCB,但两者联合性能更佳。

要点

  • KFLC-Index在MOGAD组最低(中位数0.60),NMOSD组居中(8.85),MS组最高(49.90)。
  • 鉴别MOGAD与MS的AUC为0.93,最佳阈值5.7,敏感度0.89,特异度0.89。
  • KFLC-Index与OCB联合使用优于单独检测,可作为鉴别MOGAD与MS的补充支持指标。

核心结论

  • KFLC-Index是区分MS与AQP4-NMOSD及MOGAD的有价值工具,可提供OCB以外的补充信息。
  • 建议将KFLC-Index作为MOGAD与MS鉴别诊断的附加支持标准。

研究设计与样本

  • 回顾性病例对照研究,通过法国国家NOMADMUS数据库在18个中心开展。
  • 纳入303例患者,包括140例MOGAD、37例AQP4-NMOSD和126例MS(来自里昂中心作为对照)。
  • 入组条件为确诊MOGAD或AQP4-NMOSD且OCB状态和KFLC-Index水平可获取或可回顾性检测。

主要发现

  • KFLC-Index中位数(四分位距)在MOGAD组最低为0.60(0.33-2.09),71%患者脑脊液KFLC不可测。
  • NMOSD组KFLC-Index中位数为8.85(3.04-16.78),MS组最高为49.90(16.31-113.39)。
  • 鉴别MOGAD与MS的AUC为0.93(95%CI 0.9-0.96),最佳阈值5.7(95%CI 4.74-6.85),敏感度0.89(0.83-0.94),特异度0.89(0.83-0.94)。
  • 鉴别NMOSD与MS的AUC为0.82(95%CI 0.74-0.88),鉴别MOGAD与NMOSD的AUC为0.77(95%CI 0.69-0.86)。
  • KFLC-Index在区分MOGAD与MS及NMOSD与MS方面未显著优于OCB,但两试验联合性能优于单独使用。

关键数值与推荐

  • MOGAD与MS鉴别:KFLC-Index最佳阈值5.7,AUC 0.93,敏感度0.89,特异度0.89。
  • NMOSD与MS鉴别:AUC 0.82(95%CI 0.74-0.88)。
  • MOGAD与NMOSD鉴别:AUC 0.77(95%CI 0.69-0.86)。

临床怎么用

  • 对于疑似MOGAD或MS患者,可检测脑脊液KFLC-Index辅助鉴别诊断。
  • KFLC-Index应与OCB联合解读,联合检测可提高鉴别性能。
  • KFLC-Index可作为MOGAD与MS鉴别诊断的附加支持标准。

局限性

  • 回顾性病例对照设计可能存在选择偏倚。
  • MS对照组仅来自单一中心(里昂),可能影响代表性。
  • 部分患者OCB状态和KFLC-Index水平为回顾性检测,可能存在检测方法差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The differential diagnosis between aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD), and multiple sclerosis (MS) can be complex. Kappa free light chain index (KFLC-Index) emerged as an effective biomarker for distinguishing patients with MS from patients with other conditions. The main aim of this study was to assess the diagnostic performance of KFLC-Index in differentiating MOGAD, AQP4-NMOSD, and MS and to compare it with CSF-restricted oligoclonal bands (OCB) performance. METHODS: We conducted a retrospective case-control study involving 18 French centers through our national NOMADMUS database. Patients were eligible if they received MOGAD or AQP4-NMOSD diagnosis and if OCB status and KFLC-Index levels were available or could be measured retrospectively. As a comparator, we included a group of patients with MS from the Lyon center. RESULTS: We included 303 patients with 140 MOGAD, 37 AQP4-NMOSD, and 126 MS. The sex ratio F/M was 1/1 in the MOGAD group, 5/1 in the NMOSD group, and 4/1 in the MS group. The median age was 38 years in the MOGAD group, 52 in the NMOSD group, and 32 in the MS group. The median KFLC-Index (interquartile range) was the lowest in the MOGAD group (0.60 [0.33-2.09]) with 71% of undetectable CSF-KFLC, intermediate in the NMOSD group (8.85 [3.04-16.78]), and the highest in the MS group (49.90 [16.31-113.39]). KFLC-Index had very good diagnostic performance in differentiating MOGAD from MS (area under the curve [AUC] 0.93, 95% CI 0.9-0.96) with an optimal threshold of 5.7 (95% CI 4.74-6.85), a sensitivity of 0.89 (0.83-0.94), and a specificity of 0.89 (0.83-0.94). KFLC-Index had good performance in differentiating NMOSD from MS (AUC 0.82, 95% CI 0.74-0.88) and MOGAD from NMOSD (AUC 0.77, 95% CI 0.69-0.86). KFLC-Index did not significantly outperformed OCB in separating MOGAD from MS and NMOSD from MS; however, the combination of the 2 tests was more performant than used separately. DISCUSSION: KFLC-Index is a valuable tool in distinguishing MS from AQP4-NMOSD and MOGAD and provides additional information to that given by OCB. We suggest that KFLC-Index as an additional supporting criterion for the differential diagnosis between MOGAD and MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tournier A, Gavoille A, Pique J, et al. Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS. Neurology. 2026. PMID: 41921124. doi:10.1212/WNL.0000000000214806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。